-
1
-
-
0035205181
-
Frequency distribution of collateral flow and factors influencing collateral channel development: Functional collateral channel measurement in 450 patients with coronary artery disease
-
DOI 10.1016/S0735-1097(01)01675-8, PII S0735109701016758
-
Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and actors influencing collateral channel development: functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872-78. (Pubitemid 33116557)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.7
, pp. 1872-1878
-
-
Pohl, T.1
Seiler, C.2
Billinger, M.3
Herren, E.4
Wustmann, K.5
Mehta, H.6
Windecker, S.7
Eberli, F.R.8
Meier, B.9
-
2
-
-
12344288420
-
Growth factor-induced therapeutic angiogenesis in the heart: Protein therapy
-
DOI 10.1016/j.cardiores.2004.09.004, PII S000863630400389X
-
Annex BH, Simons M. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res 2005; 65:649-55. (Pubitemid 40138985)
-
(2005)
Cardiovascular Research
, vol.65
, Issue.3
, pp. 649-655
-
-
Annex, B.H.1
Simons, M.2
-
3
-
-
9344246863
-
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
-
DOI 10.1161/01.RES.0000149165.99974.12
-
Collin-Osdoby P. Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin. Circ Res 2004; 95:1046-57. (Pubitemid 39557891)
-
(2004)
Circulation Research
, vol.95
, Issue.11
, pp. 1046-1057
-
-
Collin-Osdoby, P.1
-
4
-
-
7344233085
-
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
-
DOI 10.1074/jbc.273.23.14363
-
Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998; 273:14363-7. (Pubitemid 28319153)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.23
, pp. 14363-14367
-
-
Emery, J.G.1
McDonnell, P.2
Burke, M.B.3
Deen, K.C.4
Lyn, S.5
Silverman, C.6
Dul, E.7
Appelbaum, E.R.8
Eichman, C.9
DiPrinzio, R.10
Dodds, R.A.11
James, I.E.12
Rosenberg, M.13
Lee, J.C.14
Young, P.R.15
-
5
-
-
61449157230
-
Marta Scatena. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
-
McGonigle JS, Giachelli CM. Marta Scatena. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. Angiogenesis 2009; 12:35-46.
-
(2009)
Angiogenesis
, vol.12
, pp. 35-46
-
-
McGonigle, J.S.1
Giachelli, C.M.2
-
6
-
-
0033984313
-
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
-
Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15:2-12. (Pubitemid 30026926)
-
(2000)
Journal of Bone and Mineral Research
, vol.15
, Issue.1
, pp. 2-12
-
-
Hofbauer, L.C.1
Khosla, S.2
Dunstan, C.R.3
Lacey, D.L.4
Boyle, W.J.5
Riggs, B.L.6
-
7
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
DOI 10.1016/S0092-8674(00)81569-X
-
Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-76. (Pubitemid 28180851)
-
(1998)
Cell
, vol.93
, Issue.2
, pp. 165-176
-
-
Lacey, D.L.1
Timms, E.2
Tan, H.-L.3
Kelley, M.J.4
Dunstan, C.R.5
Burgess, T.6
Elliott, R.7
Colombero, A.8
Elliott, G.9
Scully, S.10
Hsu, H.11
Sullivan, J.12
Hawkins, N.13
Davy, E.14
Capparelli, C.15
Eli, A.16
Qian, Y.-X.17
Kaufman, S.18
Sarosi, I.19
Shalhoub, V.20
Senaldi, G.21
Guo, J.22
Delaney, J.23
Boyle, W.J.24
more..
-
8
-
-
0032584208
-
Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
-
Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95:3597-02.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 3597-3602
-
-
Yasuda, H.1
Shima, N.2
Nakagawa, N.3
-
9
-
-
0034817070
-
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
-
DOI 10.1006/bbrc.2000.4130
-
Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 280:334-39. (Pubitemid 32917516)
-
(2001)
Biochemical and Biophysical Research Communications
, vol.280
, Issue.1
, pp. 334-339
-
-
Hofbauer, L.C.1
Shui, C.2
Riggs, B.L.3
Dunstan, C.R.4
Spelsberg, T.C.5
O'Brien, T.6
Khosla, S.7
-
10
-
-
0035094860
-
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
-
DOI 10.1210/jc.86.2.631
-
Browner WS, Lui LY, Cummings SR. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001; 86:631-37. (Pubitemid 32207471)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.2
, pp. 631-637
-
-
Browner, W.S.1
Lui, L.-Y.2
Cummings, S.R.3
-
11
-
-
0034924233
-
Immuno-PCR assay for homodimeric osteoprotegerin
-
Furuya D, Kaneko R, Yagihashi A, Endoh T, Yajima T, Kobayashi D, Yano K, Tsuda E, Watanabe N. Immuno-PCR assay for homodimeric osteoprotegerin. Clin Chem 2001; 47:1475-77. (Pubitemid 32678832)
-
(2001)
Clinical Chemistry
, vol.47
, Issue.8
, pp. 1475-1477
-
-
Furuya, D.1
Kaneko, R.2
Yagihashi, A.3
Endoh, T.4
Yajima, T.5
Kobayashi, D.6
Yano, K.7
Tsuda, E.8
Watanabe, N.9
-
12
-
-
0032079445
-
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
-
Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegrin deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12:1260-68. (Pubitemid 28213402)
-
(1998)
Genes and Development
, vol.12
, Issue.9
, pp. 1260-1268
-
-
Bucay, N.1
Sarosi, I.2
Dunstan, C.R.3
Morony, S.4
Tarpley, J.5
Capparelli, C.6
Scully, S.7
Tan, H.L.8
Xu, W.9
Lacey, D.L.10
Boyle, W.J.11
Simonet, W.S.12
-
13
-
-
53649085238
-
Role of alpha(v) integrin in osteoprotegerin-induced endothelial cell migration and proliferation
-
Kobayashi-Sakamoto M, Isogai E, Hirose K, Chiba I. Role of alpha(v) integrin in osteoprotegerin-induced endothelial cell migration and proliferation. Microvasc Res 2008; 76:139-44.
-
(2008)
Microvasc Res
, vol.76
, pp. 139-144
-
-
Kobayashi-Sakamoto, M.1
Isogai, E.2
Hirose, K.3
Chiba, I.4
-
14
-
-
4043110456
-
Osteoprotegerin gene polymorphisms in men with coronary artery disease
-
DOI 10.1210/jc.2003-032054
-
Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab 2004; 89:3764-68. (Pubitemid 39071469)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.8
, pp. 3764-3768
-
-
Soufi, M.1
Schoppet, M.2
Sattler, A.M.3
Herzum, M.4
Maisch, B.5
Hofbauer, L.C.6
Schaefer, J.R.7
-
15
-
-
0037015255
-
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
-
DOI 10.1161/01.CIR.0000031524.49139.29
-
Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106:1192-94. (Pubitemid 34988634)
-
(2002)
Circulation
, vol.106
, Issue.10
, pp. 1192-1194
-
-
Jono, S.1
Ikari, Y.2
Shioi, A.3
Mori, K.4
Miki, T.5
Hara, K.6
Nishizawa, Y.7
-
16
-
-
2442492972
-
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
-
DOI 10.1161/01.CIR.0000127957.43874.BB
-
Kiechl S, Schert G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004; 109:2175-80. (Pubitemid 38625393)
-
(2004)
Circulation
, vol.109
, Issue.18
, pp. 2175-2180
-
-
Kiechl, S.1
Schett, G.2
Wenning, G.3
Redlich, K.4
Oberhollenzer, M.5
Mayr, A.6
Santer, P.7
Smolen, J.8
Poewe, W.9
Willeit, J.10
-
17
-
-
33645820419
-
Circulating osteoprotegrin and soluble RANKL: Do they have a future in clinical practice?
-
Dovio A, Data V, Angeli A. Circulating osteoprotegrin and soluble RANKL: do they have a future in clinical practice? J Endocrinol Invest 2005; 28:14-22.
-
(2005)
J Endocrinol Invest
, vol.28
, pp. 14-22
-
-
Dovio, A.1
Data, V.2
Angeli, A.3
-
18
-
-
67349099856
-
Osteoprotegerin, vascular calcification and atherosclerosis
-
Campenhout AV, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 2009; 204:321-29.
-
(2009)
Atherosclerosis
, vol.204
, pp. 321-329
-
-
Campenhout, A.V.1
Golledge, J.2
-
19
-
-
42349105256
-
Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions
-
Kinnaird T, Stabile E, Zbinden S, Burnett M, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovascular Research 2008; 78:257-64.
-
(2008)
Cardiovascular Research
, vol.78
, pp. 257-264
-
-
Kinnaird, T.1
Stabile, E.2
Zbinden, S.3
Burnett, M.4
Epstein, S.E.5
-
20
-
-
0021923120
-
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
-
Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-92. (Pubitemid 15141963)
-
(1985)
Journal of the American College of Cardiology
, vol.5
, Issue.3
, pp. 587-592
-
-
Rentrop, K.P.1
Cohen, M.2
Blanke, H.3
Phillips, R.A.4
-
21
-
-
33646441388
-
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: Possible role in plaque destabilization
-
DOI 10.1161/01.ATV.0000204334.48195.6a, PII 0004360520060400000028
-
Sandberg WJ, Yndestad A, Øie E, et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 2006; 26:857-63. (Pubitemid 43732163)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.4
, pp. 857-863
-
-
Sandberg, W.J.1
Yndestad, A.2
Oie, E.3
Smith, C.4
Ueland, T.5
Ovchinnikova, O.6
Robertson, A.-K.L.7
Muller, F.8
Semb, A.G.9
Scholz, H.10
Andreassen, A.K.11
Gullestad, L.12
Damas, J.K.13
Froland, S.S.14
Hansson, G.K.15
Halvorsen, B.16
Aukrust, P.17
-
22
-
-
33750569832
-
Transcriptional profiling in coronary artery disease: Indications for novel markers of coronary collateralization
-
DOI 10.1161/CIRCULATIONAHA.106.628396, PII 0000301720061024000007
-
Chittenden TW, Sherman JA, Xiong F, et al. Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation. 2006; 114:1811-20. (Pubitemid 44673356)
-
(2006)
Circulation
, vol.114
, Issue.17
, pp. 1811-1820
-
-
Chittenden, T.W.1
Sherman, J.A.2
Xiong, F.3
Hall, A.E.4
Lanahan, A.A.5
Taylor, J.M.6
Duan, H.7
Pearlman, J.D.8
Moore, J.H.9
Schwartz, S.M.10
Simons, M.11
-
23
-
-
33845898720
-
The osteoprotegerin/RANK/RANKL system: A bone key to vascular disease
-
DOI 10.1586/14779072.4.6.801
-
Kiechl S, Werner P, Knoflach M, et al. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. Expert Rev Cardiovasc Ther 2006; 4:801-11. (Pubitemid 46017520)
-
(2006)
Expert Review of Cardiovascular Therapy
, vol.4
, Issue.6
, pp. 801-811
-
-
Kiechl, S.1
Werner, P.2
Knoflach, M.3
Furtner, M.4
Willeit, J.5
Schett, G.6
-
24
-
-
2442492972
-
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
-
DOI 10.1161/01.CIR.0000127957.43874.BB
-
Kiechl S, Schett G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004; 109:2175-80. (Pubitemid 38625393)
-
(2004)
Circulation
, vol.109
, Issue.18
, pp. 2175-2180
-
-
Kiechl, S.1
Schett, G.2
Wenning, G.3
Redlich, K.4
Oberhollenzer, M.5
Mayr, A.6
Santer, P.7
Smolen, J.8
Poewe, W.9
Willeit, J.10
-
25
-
-
8144227919
-
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
-
DOI 10.1016/j.jacc.2004.06.076, PII S073510970401705X
-
Ueland T, Jemtland R, Godang K, et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 2004; 44:1970-76. (Pubitemid 39473280)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.10
, pp. 1970-1976
-
-
Ueland, T.1
Jemtland, R.2
Godang, K.3
Kjekshus, J.4
Hognestad, A.5
Omland, T.6
Squire, I.B.7
Gullestad, L.8
Bollerslev, J.9
Dickstein, K.10
Aukrust, P.11
-
26
-
-
33747423277
-
-/- mice
-
DOI 10.1161/01.ATV.0000236428.91125.e6, PII 0004360520060900000029
-
Bennett BJ, Scatena M, Kirk EA, et al. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol 2006; 26:2117-24. (Pubitemid 44253797)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.9
, pp. 2117-2124
-
-
Bennett, B.J.1
Scatena, M.2
Kirk, E.A.3
Rattazzi, M.4
Varon, R.M.5
Averill, M.6
Schwartz, S.M.7
Giachelli, C.M.8
Rosenfeld, M.E.9
-
27
-
-
38349133382
-
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
-
Morony S, Tintut Y, Zhang Z, et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 2008; 117:411-20.
-
(2008)
Circulation
, vol.117
, pp. 411-420
-
-
Morony, S.1
Tintut, Y.2
Zhang, Z.3
-
28
-
-
33645221176
-
Osteoprotegerin (OPG):a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
-
Cross SS, Yang Z, Brown NJ, et al. Osteoprotegerin (OPG):a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? Int J Cancer 2006; 118:1901-8.
-
(2006)
Int J Cancer
, vol.118
, pp. 1901-1908
-
-
Cross, S.S.1
Yang, Z.2
Brown, N.J.3
|